90 results
8-K
PLSE
Pulse Biosciences, Inc.
12 Aug 24
Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results
4:15pm
his term expires at the annual meeting of stockholders to be held in 2025 and until his successor is elected and qualified or until his earlier death
424B5
PLSE
Pulse Biosciences, Inc.
15 Jul 24
Prospectus supplement for primary offering
7:04am
it is used to stimulate primarily regulated cell death, such as through nsPFA ablation, we believe it will be less traumatic to treated tissue … , which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way
424B2
PLSE
Pulse Biosciences, Inc.
4 Jun 24
Prospectus for primary offering
4:05pm
, give away or otherwise transfer your rights. However, rights will be transferable as required by operation of law, for example, upon the death … technology can influence many cellular functions depending on the energy applied. When it is used to stimulate primarily regulated cell death
POS AM
PLSE
Pulse Biosciences, Inc.
28 May 24
Prospectus update (post-effective amendment)
5:19pm
or otherwise transfer your rights. However, rights will be transferable as required by operation of law, for example, upon the death of the recipient.
Q … influence many cellular functions depending on the energy applied. When it is used to stimulate primarily regulated cell death, such as through nsPFA
8-K
EX-10.3
PLSE
Pulse Biosciences, Inc.
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
to Participant’s death or Disability, in which case this Option will be exercisable for twelve (12) months after Participant ceases to be a Service
8-K
el93xzfls6ad
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-10.1
duk86n 4u1ir2
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
8-K
EX-10.2
5c5a89n039deoiu
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am